Revista de Gastroenterologia de Mexico最新文献

{"title":"Respuesta a Teco-Cortes J.A. Primer consenso mexicano de la enfermedad de Crohn. El punto de vista del patólogo","authors":"J.K. Yamamoto-Furusho","doi":"10.1016/j.rgmx.2025.01.002","DOIUrl":"10.1016/j.rgmx.2025.01.002","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Page 343"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validación de la prueba de denominación de animales para el diagnóstico de la encefalopatía hepática mínima","authors":"A.D. Cano-Contreras ,&nbsp;J.A. Velarde-Ruiz Velasco ,&nbsp;F. Higuera-de-la-Tijera ,&nbsp;C.F. Castillo-Diaz ,&nbsp;D. Grajales-Velázquez ,&nbsp;I. Méndez-Ruiz ,&nbsp;V.A. Jiménez-Hernández ,&nbsp;R. Aguirre-Lázaro ,&nbsp;J.A. Sánchez-Hernández ,&nbsp;H.R. Ordaz-Álvarez ,&nbsp;J.M. Remes-Troche","doi":"10.1016/j.rgmx.2024.09.003","DOIUrl":"10.1016/j.rgmx.2024.09.003","url":null,"abstract":"<div><h3>Introduction and aim</h3><div>The diagnosis of minimal hepatic encephalopathy (MHE) is complex in clinical practice, given that its adequate evaluation is time-consuming. The animal naming test (ANT1) has proven to be a useful tool for rapid MHE identification. Our aim was to validate the ANT1 in a cohort of Mexican patients with cirrhosis of the liver.</div></div><div><h3>Material and methods</h3><div>An observational, cross-sectional, and analytic study was conducted within the time frame of June 2022 and May 2023. MHE diagnosis was made using the psychometric hepatic encephalopathy score (PHES). Patients with overt HE evaluated through the West Haven criteria were excluded. The ANT1 was performed on all participants.</div></div><div><h3>Results</h3><div>A total of 199 patients with cirrhosis and 31 non-cirrhotic control subjects were analyzed. Women predominated (61.8% and 71%) and mean patient age was 55<!--> <!-->± 10 and 53.6<!--> <!-->±<!--> <!-->12 (range 19 to 84 years), respectively. Ninety patients (45.2%) met the MHE criteria determined by the PHES. Using an ANT1 cutoff point of<!--> <!-->≤<!--> <!-->15, MHE was identified in 65 (32.7%) patients, along with 75% sensitivity, 72% specificity, 53% positive predictive value, 87% negative predictive value, and 73% diagnostic accuracy. The area under the curve for diagnosing MHE was 0.763 (standard error, 0.081; 95% confidence interval, 0.604-0.923; p<!--> <!-->≤<!--> <!-->0.0001).</div></div><div><h3>Conclusions</h3><div>The ANT1 was shown to be a useful tool for identifying MHE in daily clinical practice. In our population, a cutoff point<!--> <!-->≤<!--> <!-->15 animals named could be utilized for rapid screening of patients at high risk for progressing to overt HE, who would then require extensive testing.</div></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 192-198"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mala absorción de ácidos biliares (MAAB): una causa pocas veces sospechada de diarrea crónica. Hacia un diagnóstico eficiente y económico","authors":"J.M. Remes-Troche","doi":"10.1016/j.rgmx.2025.01.003","DOIUrl":"10.1016/j.rgmx.2025.01.003","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 167-168"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tumor desmoide: análisis clínico y revisión de literatura","authors":"M.A. Urbina ,&nbsp;O. Melin ,&nbsp;P. Galindo ,&nbsp;E. Sánchez ,&nbsp;J.E. González","doi":"10.1016/j.rgmx.2024.12.004","DOIUrl":"10.1016/j.rgmx.2024.12.004","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 325-327"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Características de la alimentación de los pacientes mexicanos con síndrome de intestino irritable. ¿Se distingue de la población general?","authors":"M. Amieva-Balmori,&nbsp;G.P. Martínez-Pérez,&nbsp;M.R. Francisco,&nbsp;A. Triana-Romero,&nbsp;A.A. Ortiz-Lorenzo,&nbsp;G.A. Hernández-Ramírez,&nbsp;J.A. Martínez-Conejo,&nbsp;G.A. Violante-Hernández,&nbsp;A.D. Cano-Contreras,&nbsp;J.M. Remes-Troche","doi":"10.1016/j.rgmx.2024.09.010","DOIUrl":"10.1016/j.rgmx.2024.09.010","url":null,"abstract":"<div><h3>Introduction</h3><div>Irritable bowel syndrome (IBS) is a multifactorial condition, in which diet is a main trigger of symptoms. Many patients modify their diet without professional supervision, which can cause nutritional risks or aggravate symptoms. The aim of this study was to evaluate the dietary intake of patients with IBS versus healthy subjects.</div></div><div><h3>Material and methods</h3><div>An observational, analytic, cross-sectional study was conducted on 108 subjects: 77 (71.3%) diagnosed with IBS (Rome IV criteria) and 31 (28.7%) healthy controls. Patient age was from 18 to 66 years and the woman-to-man ratio was 4.1:1. Both groups completed a 7-day food diary, registering their usual diet that was then analyzed using a nutrition software program.</div></div><div><h3>Results</h3><div>Macronutrient intake was similar between the two groups but the patients with IBS had a significantly higher intake of vitamins D (<em>P</em>≤.001), B₁ (<em>P</em>≤.001), B₂ (<em>P</em>≤.001), and B₃ (<em>P</em>≤.001). There was greater vitamin B₃ intake in patients with an IBS subtype (<em>P</em> =.005). There were no significant differences in fiber consumption.</div></div><div><h3>Conclusion</h3><div>The diet of Mexican patients with IBS was slightly different from that of healthy subjects. The IBS patients consumed more fiber and their FODMAP intake was similar to that of the healthy controls. Even though the majority of the IBS patients met the recommendations for macronutrient and micronutrient intake, nutritional guidance in the management of IBS is recommended because dietary adjustments can significantly improve symptoms.</div></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 182-191"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Eficacia del uso de polvo hemostático para el manejo endoscópico de la hemorragia digestiva alta de origen tumoral","authors":"J.P. Pérez-Macías,&nbsp;M.E. Ramírez- Solís,&nbsp;A.I. Hernández-Guerrero,&nbsp;J.G. Dela Mora- Levy,&nbsp;W.D. Torrecilla- Ramírez,&nbsp;B.A. Sánchez-Jiménez,&nbsp;G.M. Salgado-Castellón","doi":"10.1016/j.rgmx.2024.10.004","DOIUrl":"10.1016/j.rgmx.2024.10.004","url":null,"abstract":"<div><h3>Introduction</h3><div>Upper gastrointestinal bleeding (UGIB) of neoplastic origin is a rare but life-threatening cause of bleeding. Endoscopic treatment is challenging due to diffuse oozing blood and high rates of rebleeding, despite coagulation and hemoclip use. Hemostatic powders can be an option in those patients. We aimed to determine the initial hemostatic rate and the rebleeding rate at 7 and 30 days, using hemostatic powders in patients with malignant UGIB at a national referral center in Mexico.</div></div><div><h3>Material and methods</h3><div>A retrospective, observational study was conducted on patients with malignant UGIB treated with hemostatic powder between 2018-2023. Demographic and clinical variables, endoscopic findings, and treatment results were analyzed. A central tendency analysis and the chi-square test were employed.</div></div><div><h3>Results</h3><div>The study included 54 patients (54.7% were men), with a mean age of 54 years. A total of 40.7% were diagnosed with gastric cancer and presented with an episode of malignant UGIB. Of the endoscopic findings, 52% of patients had active malignant UGIB, most presenting with oozing bleeding (57.4%). EndoClot™ was the main monotherapy employed (81.5%), achieving initial homeostasis in 100% of cases. The rebleeding rate was 22.2% at 7 days and 44.4% at 30 days, with a 30-day accumulated mortality rate of 35.2%.</div></div><div><h3>Conclusions</h3><div>Malignant UGIB is a potentially life-threatening complication. Hemostatic powder use is highly recommendable due to its efficacy in the immediate control of bleeding. Nevertheless, its effect is temporary, suggesting its use as bridging therapy, facilitating bleeding stabilization and enabling the implementation of definitive hemostatic treatments.</div></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 199-206"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recomendaciones de buena práctica clínica para el uso de neuromoduladores en gastroenterología: revisión conjunta de expertos de la Asociación Mexicana de Gastroenterología (AMG) y Asociación Mexicana de Neurogastroenterología y Motilidad (AMNM)","authors":"O. Gómez-Escudero ,&nbsp;J.M. Remes-Troche ,&nbsp;E. Coss-Adame ,&nbsp;K.R. García-Zermeño ,&nbsp;J. Aquino-Matus ,&nbsp;J. Jiménez-Pavón ,&nbsp;L.R. Valdovinos-García ,&nbsp;M.A. Vargas-Martínez ,&nbsp;M. Amieva-Balmori ,&nbsp;J.S. Arenas-Martínez ,&nbsp;F.A. Félix-Téllez ,&nbsp;P.C. Gómez-Castaños ,&nbsp;M. Mejía-Rivas ,&nbsp;M.A. Valdovinos-Díaz ,&nbsp;G. Vázquez-Elizondo ,&nbsp;A.S. Villar-Chávez ,&nbsp;C.P. Gyawali","doi":"10.1016/j.rgmx.2024.12.001","DOIUrl":"10.1016/j.rgmx.2024.12.001","url":null,"abstract":"<div><div>Disorders of gut-brain interaction (DGBI) are characterized by alterations in both central and peripheral gut-brain axis (GBA)-related stimuli, and include esophageal, gastroduodenal, intestinal and anorectal disorders. Despite the fact that several pathophysiologic mechanisms are involved, the mainstay of treatment is neuromodulators, a heterogeneous group of drugs that act on pathways related to central and peripheral pain processing. This expert review by both the AMG (Asociación Mexicana de Gastroenterología) and AMNM (Asociación Mexicana de Neurogastroenterología y Motilidad) summarizes a series of updated clinical recommendations based on an exhaustive review of the literature, regarding the use of neuromodulators for DGBI, and is grouped into six sections: pharmacologic principles, definition, classification, mechanism of action; indications and use in each DGBI subtype; up/downscaling strategies, combination therapy; adverse events; joint use along with psychiatry in the case of comorbidities; and non-pharmacologic neuromodulation. Furthermore, drug selection process tips and dose personalization according to individual groups and sensitivities are provided, and special cases with DGBI-psychiatric comorbidity, as well as overlap with another DGBI, are considered.</div></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 252-287"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Síndrome de Boerhaave: reporte de caso de tratamiento conservador exitoso","authors":"D.C. Calderón-Cabrera ,&nbsp;E.J. Cobián-Cerna ,&nbsp;C. Zanabria-Caya","doi":"10.1016/j.rgmx.2024.11.003","DOIUrl":"10.1016/j.rgmx.2024.11.003","url":null,"abstract":"","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 318-319"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trasplante de microbiota fecal mediante colonoscopia para el manejo del síndrome de intestino irritable refractario: resultados preliminares","authors":"C. von Muhlenbrock ,&nbsp;P. Núñez ,&nbsp;K. Herrera ,&nbsp;N. Pacheco ,&nbsp;R. Quera","doi":"10.1016/j.rgmx.2025.03.001","DOIUrl":"10.1016/j.rgmx.2025.03.001","url":null,"abstract":"<div><div>Recent studies have explored the role of the microbiota in disorders of gut-brain interaction, opening pathways for therapies, such as dietary adjustments, probiotics, and fecal microbiota transplantation (FMT). We present herein a pilot study on 4<!--> <!-->patients with severe irritable bowel syndrome (IBS), refractory to conventional treatment, in which FMT through colonoscopy showed improvement in pain, bloating, and stool consistency that was maintained during the 6-month follow-up. To establish the broader clinical application of FMT, more research on its efficacy according to instillation site and patient results is needed.</div></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 334-337"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efecto de reunión trimestral y reporte por correo electrónico de TDA, tasa de intubación cecal y tiempo de retirada sobre medidas de calidad personales y de grupo en colonoscopia","authors":"F.I. Téllez-Ávila ,&nbsp;B. Bailey ,&nbsp;S. Dehmel ,&nbsp;M. Deneke ,&nbsp;K. Rude ,&nbsp;S. Inamdar ,&nbsp;M. García","doi":"10.1016/j.rgmx.2024.11.011","DOIUrl":"10.1016/j.rgmx.2024.11.011","url":null,"abstract":"<div><h3>Introduction</h3><div>Colonoscopy is the most utilized screening test for colorectal cancer (CRC). The adenoma detection rate (ADR), cecal intubation rate (CIR), and withdrawal time (WT) are established quality indicators (QIs) for colonoscopy. The aim was to measure the effect of individual and group QIs in colonoscopy by providing quarterly meetings and email feedback on ADR, CIR, and WT.</div></div><div><h3>Material and methods</h3><div>This is a prospective study in two steps. In the initial phase, we aimed to collect the QIs in colonoscopy from our division and in the second step, we aimed to assess the impact of a quarterly report. <em>Pre-Intervention:</em> Using electronic medical records (EMRs), an automated method for calculating the ADR was devised. ADRs from 6<!--> <!-->months were obtained. <em>Periodic Feedback:</em> Endoscopists received quarterly feedback during staff meetings and emails for 9<!--> <!-->months. <em>Post-Intervention:</em> QIs were recalculated for 8<!--> <!-->months, and physicians did not receive reports.</div></div><div><h3>Results</h3><div>Over 23 months, 1,137 screening colonoscopies were conducted. Seven gastroenterologists participated, distributed into high (n<!--> <!-->=<!--> <!-->6) and low (n<!--> <!-->=<!--> <!-->1) detector groups. The mean patient age was 58.6<!--> <!-->±<!--> <!-->9.2 years, with 659 (57.9%) females. Moderate sedation was used in 892 (78.4%) cases. QIs did not show significant improvement during the feedback or post-intervention periods compared with the pre-intervention period. Endoscopists initially categorized as «low detectors» exhibited the most substantial improvement, with the ADR increasing from 23.5% to 61.5% (<em>P</em> <!-->&lt;<!--> <!-->.001).</div></div><div><h3>Conclusion</h3><div>Quarterly feedback and email reports did not significantly improve colonoscopy quality measures. Regarding the ADR, the intervention's impact was most prominent in «low detectors.»</div></div>","PeriodicalId":51767,"journal":{"name":"Revista de Gastroenterologia de Mexico","volume":"90 2","pages":"Pages 207-213"},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}